"China Paroxetine Market, 2010-2019" now available at Fast Market Research

From: Fast Market Research, Inc.
Published: Tue Jul 28 2015

According to WHO, depression, an affective mental disorder, is quite common with an incidence of 3-5%. Currently, the number of depression patients has exceeded 90 million in China and still keeps increasing. It is expected that by 2020, depression will become the second biggest threat to human health.
As a drug of the selective serotonin reuptake inhibitor (SSRI) type, paroxetine is mainly used for the treatment of depression, obsessive-compulsive disorder and social anxiety and is among one of the three SSRI drugs with certain efficacy (the other two being fluoxetine and paroxetine).
Paroxetine develops fast after entering China despite a slight decline in 2014, annual sales value rising from less than CNY 60 million in 2005 to CNY 204 million in 2013 and CAGR during this period reaching up to 17.3%. Sino-American Tianjin Smith Kline & French Laboratories Ltd, GlaxoSmithKline plc (CA), Beijing Wansheng Pharmaceutical Co., Ltd, Zhejiang Huahai Pharmaceutical Co., Ltd and Zhejiang Jianfeng Pharmaceutical Holdings occupy the majority of the Chinese market, among which Sino-American Tianjin Smith Kline & French Laboratories Ltd had the largest market share of about 69% for sales value in 2014.
With the increased mental pressure brought about by economic development and lifestyle change, the number of depression patients keeps growing too. Therefore, the market size of paroxetine is expected to expand in the next few years in China.

Full Report Details at
- http://www.fastmr.com/prod/1020584_china_paroxetine_20102019.aspx?afid=301

Readers can get at least the following information from this report:

* market size of paroxetine in China
* competitive landscape of paroxetine in Chinese market
* price of paroxetine made by different enterprises in China
* market outlook of paroxetine in China

The author suggests the following groups of people purchase this report:

* manufacturers of antidepressant
* investors/ research institutions interested in Chinese medicine market
* any interest in the Chinese medicine market, please contact CRI for customized survey service

Companies Mentioned in this Report: Sino-American Tianjin Smith Kline & French Laboratories Ltd, GlaxoSmithKline, Beijing Wansheng Pharmaceutical Co., Ltd, Zhejiang Huahai Pharmaceutical Co., Ltd, Zhejiang Jianfeng Pharmaceutical Holdings

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Libbs Farmaceutica Ltda - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- China Sertraline Market, 2010-2019
- Synthon BV - Strategic SWOT Analysis Review
- Zalicus Inc. - Product Pipeline Review - 2014
- Korea United Pharm, Inc. (033270) - Financial and Strategic SWOT Analysis Review

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »